It is a trading private limited company based in Allahabad, Uttar Pradesh, India, established in 2015.
2015 | Allahabad, Uttar Pradesh, India | ActiveCeflact Pharmaceuticals Private Limited, a active private limited company, was established on 22 April 2015 in Allahabad, Uttar Pradesh, India. Engaging in wholesale within the trade sector, it holds CIN: U24233UP2015PTC070273. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Niti Mishra (Director), Ashutosh Mishra (Director). Past directors included Arvind Kumar Shukla, Ram Sajiwan Mishra, Rohan Srivastava. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 327, Lig, Govindpur Housing Scheme, Allahabad, Uttar Pradesh, 211004.
U24233UP2015PTC070273
070273
22 April 2015
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Ceflact Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Niti Mishra | Director | 21 Nov 2016 | Current |
| Ashutosh Mishra | Director | 22 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 24 Nov 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ceflact Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Ceflact Pharmaceuticals had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ceflact Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ceflact Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ceflact Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ceflact Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Ceflact Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Progress on Niti Mishra was appointed as a Director was appointed as a Director on 21 Nov 2016 & has been associated with this company since 9 years 1 month . was documented.
Ashutosh Mishra was appointed as a Director was appointed as a Director on 22 Apr 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.
The activity Ceflact Pharmaceuticals Private Limited was registered on 22 Apr 2015 with Roc Kanpur & aged 10 years 8 months as per MCA records. was completed.
The CIN of Ceflact Pharmaceuticals Private Limited is U24233UP2015PTC070273.
Ceflact Pharmaceuticals Private Limited is headquartered at 327, Lig, Govindpur Housing Scheme, Allahabad, Uttar Pradesh, 211004.
Ceflact Pharmaceuticals Private Limited was incorporated on 22 April 2015.
The current directors of Ceflact Pharmaceuticals Private Limited are
The primary industry of Ceflact Pharmaceuticals Private Limited is Trade.
Ceflact Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ceflact Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Ceflact Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX